GlaxoSmithKline PLC’sbest-case scenario for growth in India includes building capacity for its consumer business there, CEO Andrew Witty says.
During a recent discussion Glaxo board members and executives conducted in New Delhi with a panel of Indian finance and pharmaceutical experts and media representatives, Witty said investing in large...